100 million possibilities
for a cure

We invent the optimal vector
to deliver the perfect solution for
each disease, and for each patient,
by pulling from our library of
over 100 million novel AAV vectors.

Vector Technology That Delivers

More

A Pipeline That Sets Us Apart

More

Contact Us

More

In The News

September 2018

4D Molecular Therapeutics Raises $90 Million Series B Fin...

More

July 2018

MedImmune and 4D Molecular Therapeutics Collaborate to Design, Develop and Commercialize AAV Gene Therapy for Chronic Lung Disease

More

4DMT In The Media

Click below to read more

More